Regeneratio

Regeneratio is a Polish biotechnology company focused on the development of innovative therapies for tissue regeneration and the treatment of chronic inflammatory diseases. The company's primary research efforts center on small molecule and peptide-based compounds designed to modulate angiogenesis and promote healing in ophthalmic and dermatological conditions. Their lead programs target vascular endothelial growth factor (VEGF) pathways to address indications such as diabetic retinopathy and age-related macular degeneration. By leveraging expertise in medicinal chemistry and molecular biology, Regeneratio aims to provide more effective and less invasive treatment options for patients with vision-threatening and skin-related disorders.